The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 06, 2017

Filed:

Dec. 09, 2015
Applicant:

Sunovion Pharmaceuticals Inc., Marlborough, MA (US);

Inventors:

Anthony John Giovinazzo, Caledon, CA;

David Bruce Hedden, Ann Arbor, MI (US);

Marc L. De Somer, Winchester, MA (US);

Nathan John Bryson, Toronto, CA;

Assignee:

Sunovion Pharmaceuticals Inc., Marlborough, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61F 13/00 (2006.01); A61K 31/485 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/20 (2006.01); A61K 9/70 (2006.01); A61K 31/473 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01);
U.S. Cl.
CPC ...
A61K 31/485 (2013.01); A61K 9/006 (2013.01); A61K 9/0056 (2013.01); A61K 9/06 (2013.01); A61K 9/2086 (2013.01); A61K 9/7007 (2013.01); A61K 31/473 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); Y10T 428/2982 (2015.01);
Abstract

Disclosed are sublingual formulations of apomorphine in unit dosage form formulated for sublingual administration, where the unit dosage form is a mucoadhesive film containing a pH neutralizing agent and apomorphine particles containing an acid addition salt of apomorphine, and where the mucoadhesive film is formed by the steps of: (i) combining a film-forming mucoadhesive polymer, apomorphine particles comprising an acid addition salt of apomorphine, and a solvent to form a mixture; and (ii) pouring the mixture onto a surface and evaporating some of the solvent to form a first film comprising the apomorphine particles, where the steps further include contacting or impregnating the first film or mixture with a pH neutralizing agent to produce the mucoadhesive film containing the apomorphine particles and the pH neutralizing agent.


Find Patent Forward Citations

Loading…